ALPINE IMMUNE SCIENCES, INC. Quarterly Current Ratio in % from Q1 2016 to Q1 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Alpine Immune Sciences, Inc. quarterly Current Ratio history and growth rate from Q1 2016 to Q1 2024.
  • Alpine Immune Sciences, Inc. Current Ratio for the quarter ending March 31, 2024 was 581 %, a 65.4% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 581 +230 +65.4% Mar 31, 2024
Q4 2023 457 +129 +39.5% Dec 31, 2023
Q3 2023 383 +88.3 +29.9% Sep 30, 2023
Q2 2023 380 +106 +38.8% Jun 30, 2023
Q1 2023 352 +87.7 +33.2% Mar 31, 2023
Q4 2022 328 +68 +26.2% Dec 31, 2022
Q3 2022 295 +40.6 +15.9% Sep 30, 2022
Q2 2022 274 +2.58 +0.95% Jun 30, 2022
Q1 2022 264 -33.3 -11.2% Mar 31, 2022
Q4 2021 260 -84 -24.5% Dec 31, 2021
Q3 2021 254 -149 -37% Sep 30, 2021
Q2 2021 271 -132 -32.7% Jun 30, 2021
Q1 2021 297 -178 -37.5% Mar 31, 2021
Q4 2020 344 -152 -30.7% Dec 31, 2020
Q3 2020 404 -124 -23.5% Sep 30, 2020
Q2 2020 403 -253 -38.6% Jun 30, 2020
Q1 2020 475 -454 -48.9% Mar 31, 2020
Q4 2019 496 -752 -60.3% Dec 31, 2019
Q3 2019 528 -1.43K -73% Sep 30, 2019
Q2 2019 656 -2.26K -77.5% Jun 30, 2019
Q1 2019 929 -1.75K -65.3% Mar 31, 2019
Q4 2018 1.25K -1.03K -45.3% Dec 31, 2018
Q3 2018 1.95K +334 +20.6% Sep 30, 2018
Q2 2018 2.92K +1.71K +142% Jun 30, 2018
Q1 2018 2.68K +1.49K +125% Mar 31, 2018
Q4 2017 2.28K +987 +76.4% Dec 31, 2017
Q3 2017 1.62K +80.8 +5.25% Sep 30, 2017
Q2 2017 1.21K -530 -30.5% Jun 30, 2017
Q1 2017 1.19K -663 -35.8% Mar 31, 2017
Q4 2016 1.29K Dec 31, 2016
Q3 2016 1.54K Sep 30, 2016
Q2 2016 1.74K Jun 30, 2016
Q1 2016 1.85K Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.